Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCRLCharles River Laboratories
FinDog View：Neutral
| Metric | AMGN | CRL |
|---|
| Close | 376.35 | 273.41 |
| Market Cap | $203B | $13.1B |
| 1M | −10.26% | −4.62% |
| P/E (TTM) | 23.3 | — |
| Forward P/E | 16.9 | 24.2 |
| P/E 5-Yr Percentile | 27 | — |
| P/S | 5.4 | 3.3 |
| P/B | 17.4 | 4.6 |
| Dividend Yield | 3.21% | — |
| Latest Quarter Revenue | $10.1B | $1.0B |
| Revenue YoY | +9.5% | −2.7% |
| Gross Margin | 72.0% | — |
| Latest Quarter EPS | 4.37 | -0.03 |
| Avg Post-Earnings Move | ±5.2% | ±1.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.60% | 2.48% |
| 90-Day Net Insider Buying | −$4.1M | −$42.6M |
AMGN · Revenue, Last 8 Quarters ($B)
CRL · Revenue, Last 8 Quarters ($B)
